Her research focus, attested by 48 publications, is on the growth hormone (GH)/insulin-like growth factor 1 (IGF1) axis and clinical issues related to child growth, including disparities in the evaluation and management of growth faltering in primary care. She is Chair of the task force charged with drafting new guidelines for GH and rhIGF1 use in children and adolescents for the Pediatric Endocrine Society and is a representative of the Pediatric Endocrine Society for the SRS Clinical Consensus.